Biodegradable and pH-Sensitive Hydrogels for Potential Colon-Specific Drug Delivery: Characterization and In Vitro Release Studies

Citations Over TimeTop 11% of 2007 papers

Abstract

A novel pH-sensitive and biodegradable composite hydrogel, based on a methacrylated and succinic derivative of dextran, named Dex-MA-SA, and a methacrylated and succinic derivative of alpha,beta-poly( N-2-hydroxyethyl)- DL-aspartamide (PHEA), named PHM-SA, was produced by photocross-linking. The goal was to obtain a colon-specific drug delivery system, exploiting both the pH-sensitive behavior and the colon-specific degradability. The hydrogel prepared with a suitable ratio between the polysaccharide and the polyaminoacid was characterized regarding its swelling behavior in gastrointestinal simulated conditions, chemical and enzymatic degradability, interaction with mucin, and cell compatibility on CaCo-2 cells. Moreover, 2-methoxyestradiol was chosen as a model of anticancer drug and release studies, were performed in the absence or in the presence of dextranase and esterase. The obtained hydrogel, due to its pH-sensitive swelling and enzymatic degradability, together with mucoadhesion and cell compatibility, could be potentially useful as system for the oral treatment of colonic cancer.

Related Papers

• → Injectable biopolymer based hydrogels for drug delivery applications(2015)103 cited
• → Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system(1999)88 cited
• → Gelatin-based hydrogels and ferrogels as smart drug delivery systems: synthesis, characterization and drug release kinetics(2023)16 cited
• → Swelling Pressure of Hydrogels That Degrade through Different Mechanisms(2004)11 cited
• → Enzyme‐based hydrogels containing dextran as drug delivery carriers: Preparation, characterization, and protein release(2009)7 cited